New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 18, 2014
04:55 EDTRHHBY, RHHBY, RHHBY, REPYY, REPYY, REPYYBarclays to hold a conference
Internationals Franchise Conference to be held in June 18-20.
News For RHHBY;REPYY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 16, 2014
10:57 EDTREPYYCanadian energy stocks rise after Talisman acquired by Repsol
Shares of Canadian energy companies are higher this morning after Repsol (REPYY) announced plans to buy Talisman Energy (TLM) for $8 per share in cash. WHAT'S NEW: Canada-based Talisman announced that it has agreed to be acquired by Spain's Repsol in a transaction valued at approximately $13B, including debt. Under the terms of the agreement, Repsol will buy all outstanding common shares of Talisman for $8 per share in cash. Also under the deal, Talisman will pay aggregate cash dividends of 18c per common share prior to closing. The Talisman board is recommending shareholders accept the deal at a special meeting to be held in mid-February 2015. The transaction is expected to close in the second quarter of 2015, Talisman said. Talisman Chairman Chuck Williamson noted that the deal will create "significant and immediate value" for the company's investors. WHAT'S NOTABLE: Repsol first explored a bid for Talisman in July, but talks slowed in late August. Earlier this month, Bloomberg reported the companies revived talks and The Wall Street Journal said "talks moved quickly" from there. Canada Pension Plan Investment Board, which initially considered buying parts of Talisman, was also weighing a bid for the whole company, according to Bloomberg, citing people with knowledge of the matter. ANALYST REACTION: Talisman Energy was downgraded this morning to Market Perform from Outperform at Bernstein. PRICE ACTION: Talisman Energy is up $2.43, or 47.5%, to $7.55 in morning trading and Repsol shares trading in New York are down 1.5% to $19.15. OTHERS TO WATCH: Other Canadian energy companies traded in New York include Encana (ECA), Suncor (SU), Canadian Natural Resource (CNQ) and Imperial Oil (IMO). Of note, Encana this morning announced a 2015 capital program of $2.7B-$2.9B, with about 80% directed to the Montney, Duvernay, Eagle Ford and Permian, its highest margin growth plays. The company expects total cash flow between $2.5B-$2.7B, reflecting the impact of higher margin production and continued cost efficiencies, partially offset by anticipated lower commodity prices. In morning trading, Encana shares rose 9.2% to $12.69, Suncor gained 5.3% to $28.33, Canadian Natural Resource added 4.8% to $28.62 and Imperial Oil advanced 2.5% to $40.88.
08:47 EDTRHHBYHemispherx Ampligen provides anti-tumor activity
Subscribe for More Information
05:46 EDTRHHBYRoche launches PCR molecular diagnostic system for point of care environment
Subscribe for More Information
05:29 EDTREPYYRepsol to acquire Talisman for $8 per share in cash
Talisman Energy (TLM) announced overnight that it has entered into a definitive agreement with Repsol (REPYY) under which Repsol will acquire all of the outstanding common shares of Talisman for $8.00 per share in cash. Total transaction value is approximately $13B, including Talisman's current debt. In addition, under the transaction, Talisman will be allowed to pay aggregate cash dividends of 18c per common share prior to closing, including the dividend declared and payable on December 31. Talisman's board has unanimously approved the transaction and recommends that Talisman's common shareholders and preferred shareholders vote in favor of the arrangement at a special meeting of shareholders to be held mid February 2015. The transaction is targeted to close in Q2 of 2015. "This deal creates significant and immediate value for Talisman stakeholders," said Chuck Williamson, Chairman of Talisman's Board of Directors. "Importantly, the deal underscores Repsol's strong belief in the high quality portfolio that Talisman has worked hard to develop. Repsol is a world-class operator with a solid track record and the financial capability to continue the development of these assets within their international portfolio. I am proud of the company that our employees, past and present, have built and I believe this transaction represents new opportunities for them in Canada and around the world."
December 15, 2014
11:43 EDTREPYYTalisman Energy confirms discussions with Repsol on potential transaction
Subscribe for More Information
10:57 EDTREPYYRepsol to submit for consideration of board possible transaction with Tailsman
Subscribe for More Information
09:37 EDTREPYYTalisman Energy bid being weighed by Canada Pension Board, Bloomberg says
Canada Pension Plan Investment Board, which initially considered buying parts of Talisman Energy (TLM), is now also weighing a bid for the whole company, according to Bloomberg, citing people with knowledge of the matter. The pension board may be competing with Spain's Repsol (REPYY), which is reportedly in talks to make a bid to buy Talisman, as previously reported. Talisman shares in New York are up about 20% in early trading. Reference Link
09:09 EDTREPYYTalisman Energy bid being weighed by Canada Pension, Bloomberg says
Subscribe for More Information
08:48 EDTREPYYTalisman Energy confirms talks with Repsol
Subscribe for More Information
05:24 EDTRHHBYExelixis announces Genentech files NDA for cobimetinib, vemurafenib combination
Exelixis (EXEL) announced its collaborator Genentech, a member of the Roche Group (RHHBY), has completed the filing of its New Drug Application, or NDA, with the FDA for cobimetinib, a specific MEK inhibitor discovered by Exelixis, in combination with vemurafenib for previously untreated patients with unresectable locally advanced or metastatic melanoma harboring a BRAF V600 mutation. Cobimetinib has received Fast Track designation by the FDA. Roche submitted a Marketing Authorization Application for the combination to the European Medicines Agency in September of this year. The NDA is based on data from the coBRIM trial, a phase 3 pivotal trial conducted by Genentech in 495 patients with BRAF V600 mutation-positive unresectable locally advanced or metastatic melanoma.
December 12, 2014
16:19 EDTREPYYOn The Fly: Closing Wrap
Subscribe for More Information
13:04 EDTREPYYOn The Fly: Midday Wrap
Subscribe for More Information
09:16 EDTREPYYRepsol in talks to buy Talisman Energy for $6-$8 per share, FT says
Spain's Repsol (REPYY) is in talks to acquire Canada's Talisman Energy (TLM) and is currently negotiating a purchase price in a range between $6 and $8 per share, said Financial Times. Such a the deal would give Talisman an enterprise value of about $10B-$12B, including debt, the report added. The Fly notes that an earlier foreign-language report from the business newspaper Expansion said that Repsol was preparing to make a bid for Talisman that values the Canadian company at around EUR 4B, or about C$6 per share. Shares of Talisman trading in New York are up 25% to $4.60 with about 15 minutes to go until the opening bell. Reference Link
08:26 EDTREPYYTalisman rises after report of Repsol mulling C$6 per share bid
Subscribe for More Information
05:52 EDTRHHBYRoche announces retirement of Genentech research head
Subscribe for More Information
December 9, 2014
12:22 EDTRHHBYPiper Jaffray biopharm analyst holds an analyst/industry conference call
Senior Research Analyst Schimmer, along with Biopharmaceuticals Analyst Breazzano, discuss gene therapy for hemophilia on an Analyst/Industry conference call to be held on December 11 at 10 am.
07:44 EDTRHHBYAmerican Association for Cancer Research to hold a symposium
Subscribe for More Information
December 8, 2014
15:38 EDTREPYYRepsol revives deal talks with Talisman Energy, Bloomberg reports
Subscribe for More Information
15:23 EDTREPYYTalisman halted for circuit-breaker after report of Repsol talks being renewed
Subscribe for More Information
15:21 EDTREPYYRepsol revives talks with Talisman Energy, Bloomberg reports
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use